Looking to publish in Neuro-Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginNeuro-Oncology is a medical oncology and neurology journal published on behalf of the Society for Neuro-Oncology. It reports a 2024 Impact Factor of 13.4 and a 2024 CiteScore of 30.2, and offers publication under either a standard licence or an open access licence.
Looking to publish in Neuro-Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Neuro-Oncology accepts the following article types. Click on an article type to view submission instructions.
Reviews
Basic And Translational Investigations
Clinical Investigations
Meta-Analyses
Systematic Reviews
Letters To The Editor
Guidelines
Recent Publications
EFTUD2-Regulated Alternative Splicing of MSH5 Drives Radioresistance in Recurrent IDH-Mutant Glioma
Qiu He, Runxin Wu, Xiaozhou Yu, Xiao Song, Maya Walker, Deanna Tiek, Tongchao Jiang, Xiao-Nan Li, Chengtao Her, Bo Hu, Shi-Yuan Cheng
Functional clustering within glioblastoma identifies a network-integrated subtype with improved survival
Danting Zeng, Abraham Z Snyder, Ki Yun Park, Benjamin T Acland, Joshua S Shimony, Eric C Leuthardt
Association between temozolomide-related hematologic toxicity and health-related quality of life (HRQoL) in patients with newly diagnosed glioblastoma
Abigirl Machingura, Johannes Weller, Johan A F Koekkoek, Linda Dirven, Matthias Preusser, Patrick Roth, Roger Stupp, Michael Weller, Madeline Pe, Thierry Gorlia, Martin J B Taphoorn, Emilie Le Rhun, Clemens Seidel
Corrigendum to: ΔNp73/ETS2 complex drives glioblastoma pathogenesis—targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma
-
Reduced-dose Radiotherapy without Chemotherapy for Intracranial Germinomas: Results from an Asian Multicenter Study
Chan Woo Wee, Hwa Kyung Byun, Yi-Wei Chen, Jaeho Cho, Yu-Mei Kang, Yen-Lin Liu, Dong-Seok Kim, Kyu-Won Shim, Jung Woo Han, Chuhl Joo Lyu, I-Chun Lai, Cheng-Shien Shieh, Chang-Ok Suh, Tai-Tong Wong, Hong In Yoon, Hsin Lun Lee
Frequently asked questions
How long does it take to publish?
Papers are normally reviewed within 3-4 weeks of submission. Appeals must be submitted within 4 weeks of the decision. Authors have 3 weeks to accept or decline a transfer offer to a sister journal. Page proof corrections must be returned within 2 working days. Advance Access articles are published online soon after acceptance.
Reformat to Neuro-Oncology using Livewrite PremiumIs a cover letter required?
A cover letter addressed to the editor is required as a separate Word file. It should declare whether the manuscript or any part of it has been previously published or submitted elsewhere, whether all co-authors have read and approved the submission, and agreement to pay approximately $600 per color figure if color figures are submitted. A new cover letter is required for revised manuscripts.
Reformat to Neuro-Oncology using Livewrite PremiumWhat are the publication costs?
The journal operates a hybrid model. Standard licence publication has no licence charge, open access publication requires an APC, and certain non-open access article types incur a flat publication fee of $800 for EANO, SNO, or ASNO society members or $1000 for non-society members.
Reformat to Neuro-Oncology using Livewrite Premium